X0306 4 2014-08-27 0 0001061027 SUNESIS PHARMACEUTICALS INC SNSS 0001197350 BJERKHOLT ERIC C/O SUNESIS PHARMACEUTICALS, INC. 395 OYSTER POINT BOULEVARD, SUITE 400 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, CFO & Corp. Secretary Common Stock 2014-08-27 4 M 0 10000 1.74 A 49994 D Common Stock 2014-08-27 4 S 0 10000 8.00 D 39994 D Common Stock 73529 I See footnote Stock Option (right to buy) 1.74 2014-08-27 4 M 0 10000 0 D 2022-02-28 Common Stock 10000 115000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2013. The shares are held by the Bjerkholt/Hahn Family Trust for which reporting person is the Trustee. One forty-eighth (1/48th) of the shares subject to the Option shall vest in equal monthly installments over forty-eight (48) months measured from February 29, 2012, provided that at each such vesting date, the reporting person shall then be providing service (as defined in the Option Plan) to the Company. /s/ Eric Bjerkholt 2014-08-28